Literature DB >> 27233519

Voltage-Gated Ion Channels in the PNS: Novel Therapies for Neuropathic Pain?

Gareth R Tibbs1, David J Posson1, Peter A Goldstein2.   

Abstract

Neuropathic pain arises from injury to the nervous system. Conditions associated with neuropathic pain are diverse, and lesions and/or pathological changes in the central nervous system (CNS) or peripheral nervous system (PNS) can frequently, but not always, be identified. It is difficult to treat, with patients often on multiple, different classes of medications, all with appreciable adverse side effect profiles. Consequently, there is a pressing need for the development of new medications. The development of such therapeutics is predicated on a clear understanding of the relevant molecular and cellular processes that contribute to the development, and maintenance, of the neuropathic pain state. One proposed mechanism thought to contribute to the ontogeny of neuropathic pain is altered expression, trafficking, and functioning of ion channels expressed by primary sensory neurons. Here, we will focus on three voltage-gated ion channel families, CaV, HCN, and NaV, first reviewing the preclinical data and then the human data where it exists.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ca(V) channel; HCN channel; Na(V) channel; chemotherapy; diabetes; nerve injury

Mesh:

Substances:

Year:  2016        PMID: 27233519     DOI: 10.1016/j.tips.2016.05.002

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  43 in total

1.  Structures of the Human HCN1 Hyperpolarization-Activated Channel.

Authors:  Chia-Hsueh Lee; Roderick MacKinnon
Journal:  Cell       Date:  2017-01-12       Impact factor: 41.582

Review 2.  TFOS DEWS II pain and sensation report.

Authors:  Carlos Belmonte; Jason J Nichols; Stephanie M Cox; James A Brock; Carolyn G Begley; David A Bereiter; Darlene A Dartt; Anat Galor; Pedram Hamrah; Jason J Ivanusic; Deborah S Jacobs; Nancy A McNamara; Mark I Rosenblatt; Fiona Stapleton; James S Wolffsohn
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

Review 3.  Using automated patch clamp electrophysiology platforms in pain-related ion channel research: insights from industry and academia.

Authors:  Damian C Bell; Mark L Dallas
Journal:  Br J Pharmacol       Date:  2017-07-18       Impact factor: 8.739

4.  Isoliquiritigenin, an active ingredient of Glycyrrhiza, elicits antinociceptive effects via inhibition of Nav channels.

Authors:  Yuichi Miyamura; Suzuro Hitomi; Yuji Omiya; Izumi Ujihara; Shoichiro Kokabu; Yasuhiro Morimoto; Kentaro Ono
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-01-06       Impact factor: 3.000

5.  Alkylphenol inverse agonists of HCN1 gating: H-bond propensity, ring saturation and adduct geometry differentially determine efficacy and potency.

Authors:  Rebecca L Joyce; Nicole P Beyer; Georgia Vasilopoulos; Kellie A Woll; Adam C Hall; Roderic G Eckenhoff; Dipti N Barman; J David Warren; Gareth R Tibbs; Peter A Goldstein
Journal:  Biochem Pharmacol       Date:  2019-02-13       Impact factor: 5.858

6.  Magi-1 scaffolds NaV1.8 and Slack KNa channels in dorsal root ganglion neurons regulating excitability and pain.

Authors:  Kerri D Pryce; Rasheen Powell; Dalia Agwa; Katherine M Evely; Garrett D Sheehan; Allan Nip; Danielle L Tomasello; Sushmitha Gururaj; Arin Bhattacharjee
Journal:  FASEB J       Date:  2019-03-12       Impact factor: 5.191

Review 7.  The Use of Intravenous Lidocaine in Perioperative Medicine: Anaesthetic, Analgesic and Immune-Modulatory Aspects.

Authors:  Ingrid Wing-Sum Lee; Stefan Schraag
Journal:  J Clin Med       Date:  2022-06-20       Impact factor: 4.964

Review 8.  HCN Channel Targets for Novel Antidepressant Treatment.

Authors:  Stacy M Ku; Ming-Hu Han
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

Review 9.  Physiology and Pathophysiology of Itch.

Authors:  Ferda Cevikbas; Ethan A Lerner
Journal:  Physiol Rev       Date:  2019-12-23       Impact factor: 37.312

Review 10.  Non-canonical Molecular Targets for Novel Analgesics: Intracellular Calcium and HCN Channels.

Authors:  Daniel C Cook; Peter A Goldstein
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.